The company reported turnover of RON237.83 million (EUR53.8 million) in 2013, similar with the level registered in 2012, according to company data sent Wednesday to the Bucharest Stock Exchange.
Farmaceutica Remedia’s revenues saw a slight increase to RON239.96 million, while its costs rose 1.5% on the year to RON236.48 million in 2013.
According to the latest available data, Managing Board Chairman Valentin Norbert Tarus controls 66.5% of the company and businessman Lutz Stache indirectly holds a 16.49% stake.
On the Bucharest stock exchange Wednesday, Farmaceutica Remedia rose 8.35% at RON0.305 a share. (EUR1=RON4.4779)